Pathos is an AI-enabled, clinical-stage biotech company focused on precision oncology. It has built a next-generation development engine that integrates advanced AI, biological modeling, and a large collection of oncology patient data. The system uses thousands of AI agents to analyze data and simulate thousands of clinical trial scenarios, aiming to make drug development smarter, faster, and more precise.
The company's data foundation consists of millions of assembled oncology patient records, integrating multiple data types including genomics, transcriptomics, imaging, text, and longitudinal clinical outcomes. This asset underpins its approach to clinical trial simulation and biological modeling.
Pathos operates with a model where small teams of subject matter experts direct hundreds of AI agents to execute work at scale. The company sits at the intersection of biotechnology, pharmaceuticals, and oncology, applying its platform to drug development.
